These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19425370)

  • 1. [Antiaggregation therapy is a secondary prevention of ischemic stroke].
    Kamchatov PR; Chugunov AV; Umarova KhIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 23():58-64. PubMed ID: 19425370
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Meves and Neubauer regarding article "Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack".
    Meves SH; Neubauer H
    Stroke; 2012 Nov; 43(11):e167; author reply e168. PubMed ID: 23091124
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
    Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
    Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet function and antiaggregant therapy in ischemic stroke.
    Pettigrew LC; Wu KK
    Semin Neurol; 1986 Sep; 6(3):293-8. PubMed ID: 3332433
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary prevention of ischemic non cardioembolic stroke].
    Armario P; Pinto X; Soler C; Cardona P
    Clin Investig Arterioscler; 2015; 27(6):287-300. PubMed ID: 25771074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
    Cha JK; Jeon HW; Kang MJ
    Eur J Neurol; 2008 Dec; 15(12):1304-8. PubMed ID: 19049546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine diphosphate-induced platelet aggregation might contribute to poor outcomes in atrial fibrillation-related ischemic stroke.
    Choi JH; Cha JK; Huh JT
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e215-20. PubMed ID: 24274935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelets and stroke outcomes: state of the science.
    Meyer D
    Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antiaggregation activity of the normal cerebral vessels and in ischemia].
    Petrishchev NN; Shestakova SA; Dorokhova LN; Mel'nikova EV
    Fiziol Zh SSSR Im I M Sechenova; 1989 Nov; 75(11):1515-20. PubMed ID: 2628008
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet medications in the secondary prevention of ischemic stroke.
    Fleck JD
    Curr Neurol Neurosci Rep; 2005 Feb; 5(1):1-3. PubMed ID: 15676101
    [No Abstract]   [Full Text] [Related]  

  • 16. Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?
    Castilla-Guerra L; Fernandez-Moreno Mdel C; Navas-Alcantara MS; Jimenez-Gonzalo F
    Eur J Intern Med; 2014 Mar; 25(3):e40-1. PubMed ID: 24484620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of drugs inhibiting blood platelet activity in the treatment of cerebral ischemia].
    Kuczyńska-Zardzewiały A; Członkowska A
    Neurol Neurochir Pol; 1987; 21(2):154-60. PubMed ID: 3309705
    [No Abstract]   [Full Text] [Related]  

  • 18. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of antiaggregants in patients with neurocirculatory asthenia with the initial signs of cerebral ischemia].
    Lebedev AA; Burdakov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):48-52. PubMed ID: 2158726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.